References
Schwartz RG. Congestive heart failure and LV dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med. 1987;82:1109–18.
Blankstein R. Proceedings of the ASNC cardiac PET summit meeting, May 12,2014, Baltimore, Md.. 4. Novel applications of cardiac PET. J Nucl Card doi:10.1007/s12350-015-0210-8.
Ishida Y. Recommendations for 18F-flurodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology Recommendations. Ann Nucl Med. 2014;28:393–403.
AlJaroudi WA. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: State of the art review and focus on emerging nuclear techniques. J Nucl Card. 2014;21:271–83.
Bokhari S. (99m)TC-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidosis. Circ Cardiovasc Imaging. 2013;6:195–201.
Rights and permissions
About this article
Cite this article
Expanding the Horizons of Nuclear Cardiology: Disease Management. J. Nucl. Cardiol. 22, 1159–1160 (2015). https://doi.org/10.1007/s12350-015-0262-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-015-0262-9